| Date Filed | Type | Description |
| 10/03/2023 |
4
| GRAY MARY ANN (Director) has filed a Form 4 on BioAtla, Inc.|
Txns:
| Granted 8,676 shares
@ $0 |
|
| 07/05/2023 |
4
| GRAY MARY ANN (Director) has filed a Form 4 on BioAtla, Inc.|
Txns:
| Granted 4,916 shares
@ $0 |
|
| 06/15/2023 |
4
| GRAY MARY ANN (Director) has filed a Form 4 on BioAtla, Inc.|
Txns:
| Granted 50,000 options to buy
@ $3.55, valued at
$177.5k
|
|
| 06/08/2023 |
4
| GRAY MARY ANN (Director) has filed a Form 4 on Keros Therapeutics, Inc.|
Txns:
| Granted 10,000 options to buy
@ $48.79, valued at
$487.9k
|
|
| 05/25/2023 |
4
| GRAY MARY ANN (Director) has filed a Form 4 on RAPT Therapeutics, Inc.|
Txns:
| Granted 12,940 options to buy
@ $20.93, valued at
$270.8k
|
|
| 05/15/2023 |
4
| GRAY MARY ANN (Director) has filed a Form 4 on BioAtla, Inc.|
Txns:
| Granted 5,503 shares
@ $0 |
|
| 02/09/2023 |
4
| GRAY MARY ANN (Director) has filed a Form 4 on Compass Therapeutics, Inc.|
Txns:
| Granted 40,000 options to buy
@ $3.93, valued at
$157.2k
|
|
| 06/17/2022 |
4
| GRAY MARY ANN (Director) has filed a Form 4 on BioAtla, Inc.|
Txns:
| Granted 20,000 options to buy
@ $2.48, valued at
$49.6k
|
|
| 06/03/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/26/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/28/2022 |
4
| GRAY MARY ANN (Director) has filed a Form 4 on Compass Therapeutics, Inc.|
Txns:
| Granted 45,000 options to buy
@ $1.51, valued at
$68k
|
|
| 04/28/2022 |
3
| GRAY MARY ANN (Director) has filed a Form 3 on Compass Therapeutics, Inc. |
| 04/04/2022 |
4
| GRAY MARY ANN (Director) has filed a Form 4 on RAPT Therapeutics, Inc.|
Txns:
| Granted 3,868 options to buy
@ $21.99, valued at
$85.1k
|
|
| 03/08/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/10/2022 |
4
| GRAY MARY ANN (Director) has filed a Form 4 on PALISADE BIO, INC.|
Txns:
| Granted 48,340 options to buy
@ $2.32, valued at
$112.1k
|
|
| 12/14/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/24/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/16/2021 |
4
| GRAY MARY ANN (Director) has filed a Form 4 on BioAtla, Inc.|
Txns:
| Granted 12,307 options to buy
@ $39.64, valued at
$487.8k
|
|
| 06/03/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/26/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/02/2021 |
4
| GRAY MARY ANN (Director) has filed a Form 4 on RAPT Therapeutics, Inc.|
Txns:
| Granted 3,822 options to buy
@ $22.2, valued at
$84.8k
|
|
| 03/05/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/21/2020 |
4
| GRAY MARY ANN (Director) has filed a Form 4 on Keros Therapeutics, Inc.|
Txns:
| Granted 16,587 options to buy
@ $82.74, valued at
$1.4M
|
|
| 12/21/2020 |
3
| GRAY MARY ANN (Director) has filed a Form 3 on Keros Therapeutics, Inc. |
| 12/15/2020 |
3
| GRAY MARY ANN (Director) has filed a Form 3 on BioAtla, Inc. |
| 12/10/2020 |
4
| GRAY MARY ANN (Director) has filed a Form 4 on Sarepta Therapeutics, Inc.|
Txns:
| Exercised 967 restricted stock units
@ $0 |
|
| 06/19/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/07/2020 |
4
| GRAY MARY ANN (Director) has filed a Form 4 on Seneca Biopharma, Inc.|
Txns:
| Granted 6,000 options to buy
@ $0 |
|
| 04/02/2020 |
4
| GRAY MARY ANN (Director) has filed a Form 4 on RAPT Therapeutics, Inc.|
Txns:
| Granted 3,984 options to buy
@ $21.27, valued at
$84.7k
|
|
| 02/28/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/10/2019 |
4
| GRAY MARY ANN (Director) has filed a Form 4 on Sarepta Therapeutics, Inc.|
Txns:
| Exercised 967 restricted stock units
@ $0 |
|
| 12/06/2019 |
4
| GRAY MARY ANN (Director) has filed a Form 4 on RAPT Therapeutics, Inc.|
Txns:
| Granted 22,500 options to buy
@ $27.53, valued at
$619.4k
|
|
| 12/06/2019 |
3
| GRAY MARY ANN (Director) has filed a Form 3 on RAPT Therapeutics, Inc. |
| 10/11/2019 |
3
| GRAY MARY ANN (Director) has filed a Form 3 on Neuralstem, Inc. |
|